§ PHARMACEUTICALS
USD · PharmaceuticalsLENZ
LENZ THERAPEUTICS INC
USDSector · PharmaceuticalsBeta · 2.21
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
87 increased/new, 40 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 1.76 | EPS (TTM) | -4.08 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 4.2M | 0.4% | ±0% |
| Alpha Wave Global, LP | 3.6M | 4.2% | ±0% |
| Fidelity Management | 3.6M | 0.0% | −3% |
| Versant Venture Management, LLC | 2.7M | 17.2% | ±0% |
| BlackRock | 2.0M | 0.0% | +17% |
| Squarepoint Ops LLC | 1.5M | 0.0% | +206% |
◇ AC INTELLIGENCE
Top institutional owners for LENZ as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER64.6% · 98 holders
QUALITY / COMPOUNDER20.6% · 9 holders
PASSIVE / INDEX8.6% · 7 holders
DEALER / BANK8.0% · 21 holders
SYSTEMATIC / QUANT5.5% · 5 holders
TACTICAL / MACRO3.3% · 2 holders
INCOME / DEFENSIVE0.1% · 4 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for LENZ in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention LENZ yet.